SLEEK Trademark

Trademark Overview


On Thursday, October 14, 2021, a trademark application was filed for SLEEK with the United States Patent and Trademark Office. The USPTO has given the SLEEK trademark a serial number of 97074876. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Friday, September 27, 2024. This trademark is owned by Editas Medicine, Inc.. The SLEEK trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Cells for medical use; cell components for medical use, namely, protein RNA complexes for medical use; cell components for medical use, namely, DNA and RNA for medical use; cell components for medical use, namely, DNA and RNA vectors for medical use; cell components for medical use, namely, DNA and RNA plasmids for medical use

Pharmaceutical research and development in the fields of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, targeted genomic insertion, targeted genomic integration, genetic diseases, gene therapy and cell therapy; Medical laboratory services in the nature of gene editing for developing cells and protein RNA complexes for medical use
sleek

General Information


Serial Number97074876
Word MarkSLEEK
Filing DateThursday, October 14, 2021
Status732 - THIRD EXTENSION - GRANTED
Status DateFriday, September 27, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 7, 2023

Trademark Statements


Goods and ServicesCells for medical use; cell components for medical use, namely, protein RNA complexes for medical use; cell components for medical use, namely, DNA and RNA for medical use; cell components for medical use, namely, DNA and RNA vectors for medical use; cell components for medical use, namely, DNA and RNA plasmids for medical use
Goods and ServicesPharmaceutical research and development in the fields of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, targeted genomic insertion, targeted genomic integration, genetic diseases, gene therapy and cell therapy; Medical laboratory services in the nature of gene editing for developing cells and protein RNA complexes for medical use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 11, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, November 11, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEditas Medicine, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02141

Party NameEditas Medicine, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02141

Trademark Events


Event DateEvent Description
Monday, October 18, 2021NEW APPLICATION ENTERED
Thursday, November 11, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, July 20, 2022ASSIGNED TO EXAMINER
Monday, July 25, 2022NON-FINAL ACTION WRITTEN
Monday, July 25, 2022NON-FINAL ACTION E-MAILED
Monday, July 25, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, November 30, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 30, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 30, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, November 30, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, December 22, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 22, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 23, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 3, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 18, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 7, 2023PUBLISHED FOR OPPOSITION
Tuesday, February 7, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, September 27, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, April 4, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, September 29, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 2, 2024SOU EXTENSION 2 GRANTED
Wednesday, September 27, 2023SOU EXTENSION 1 FILED
Wednesday, September 27, 2023SOU EXTENSION 1 GRANTED
Tuesday, April 2, 2024SOU TEAS EXTENSION RECEIVED
Friday, September 27, 2024SOU TEAS EXTENSION RECEIVED
Friday, September 27, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 27, 2024SOU EXTENSION 3 FILED
Friday, September 27, 2024SOU EXTENSION 3 GRANTED
Wednesday, April 3, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 2, 2024SOU EXTENSION 2 FILED